Navigating Risks and Opportunities in Medical AI Applications The FDA’s Digital Health Advisory Committee has presented a comprehensive executive summary addressing the regulation of generative AI-enabled devices. This document outlines potential healthcare applications, regulatory challenges, and lifecycle considerations, aiming to ensure the safe deployment of these transformative technologies in medical settings. Introduction: Generative AI (GenAI) has revolutionized various sectors, including…